Sen. Markey to DoE: What About the James Doyle Case?
Senator Edward J. Markey asked the Secretary of Energy this week to expedite the investigation of the firing of James Doyle from Los Alamos National Laboratory, which occurred after Doyle published an analysis critical of U.S. nuclear weapons policy.
“I write to urge you in the strongest possible terms to quickly conclude your investigation into the recent termination of Dr. James E. Doyle, a nuclear security and non-proliferation specialist who had been employed at the Los Alamos National Laboratory (LANL) for 17 years,” Sen. Markey wrote.
“Dr. Doyle was terminated after an article he published crticizing the deterrence value of nuclear weapons was retroactively classified. At best, the Department of Energy’s (DOE) classification procedures are too vague to be uniformly applied. At worst, it appears that these classification procedures were used to silence and retaliate against those who express dissenting opinions,” he wrote.
The Doyle case generated significant controversy among his colleagues and others concerned with nuclear security policy.
In response to public concerns, the Department of Energy said it had initiated an Inspector General review of the case. But there has been no known follow-up to date.
Using the NIST as an example, the Radiation Physics Building (still without the funding to complete its renovation) is crucial to national security and the medical community. If it were to go down (or away), every medical device in the United States that uses radiation would be decertified within 6 months, creating a significant single point of failure that cannot be quickly mitigated.
The federal government can support more proactive, efficient, and cost-effective resiliency planning by certifying predictive models to validate and publicly indicate their quality.
We need a new agency that specializes in uncovering funding opportunities that were overlooked elsewhere. Judging from the history of scientific breakthroughs, the benefits could be quite substantial.
The cost of inaction is not merely economic; it is measured in preventable illness, deaths and diminished livelihoods.